Janssen Pharmaceuticals Inc., reported that patients with venous thromboembolism (VTE) taking Xarelto (rivaroxaban) who received either 10 mg or 20 mg once daily over an extended time period, had significantly fewer recurrent blood clots and similar rates of major bleeding compared to those taking 100 mg of aspirin once daily.